None
Quote | Evolus Inc. (NASDAQ:EOLS)
Last: | $11.39 |
---|---|
Change Percent: | -2.15% |
Open: | $11.69 |
Close: | $11.64 |
High: | $11.69 |
Low: | $11.35 |
Volume: | 147,496 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Evolus Inc. (NASDAQ:EOLS)
The article published in Aesthetic Surgery Journal supports safety and duration of effect for temporary improvement in the appearance of moderate to severe glabellar lines presented at the 2023 ASDS Annual Meeting Data showed duration effect of 26 weeks, or 6 months, based on a ≥ 1...
2024-04-16 10:47:43 ET More on AbbVie AbbVie: Great To Be Proven Wrong - Still Not A Buy AbbVie: Bulletproof Fundamentals AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% AbbVie keeps Humira market share near 100% despite biosimilars: rep...
Message Board Posts | Evolus Inc. (NASDAQ:EOLS)
Subject | By | Source | When |
---|---|---|---|
Big buy in $EOLS OTM $10 May calls | boraborak38 | investorshub | 04/28/2023 5:12:15 PM |
$EOLS 4Q22 CC transcript: | DewDiligence | investorshub | 03/09/2023 9:46:54 PM |
Yeah.that was the only surprise. They have been | boraborak38 | investorshub | 03/09/2023 12:54:57 AM |
The only surprise is the refreshed $250M shelf | DewDiligence | investorshub | 03/09/2023 12:14:12 AM |
No surprises here. | boraborak38 | investorshub | 03/08/2023 10:32:20 PM |
News, Short Squeeze, Breakout and More Instantly...
The article published in Aesthetic Surgery Journal supports safety and duration of effect for temporary improvement in the appearance of moderate to severe glabellar lines presented at the 2023 ASDS Annual Meeting Data showed duration effect of 26 weeks, or 6 months, based on a ≥ 1...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will present at the following investor conference in April: Event: The 23 rd Annual Needham Virtual Healthcare Conference Date...
2024-03-12 04:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...